This inventor holds 2 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1995-1997.
Company Filing History:
Years Active: 1995-1997
Title: Lora L Fitch: Innovator in Hypoglycemic Agents
Introduction
Lora L Fitch is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of hypoglycemic agents, with a focus on developing novel compounds that aid in managing blood glucose levels. With a total of 2 patents to her name, her work is recognized for its potential impact on diabetes treatment.
Latest Patents
Lora's latest patents include innovative formulations of oral hypoglycemic agents. One of her notable inventions involves antihyperglycemic compounds selected from the group consisting of C-substituted pentacycloazoles and N-alkyl-substituted pentacycloazoles. Additionally, she has developed benzamide and sulfonamide hypoglycemic agents, which provide novel formulations and intermediates useful for lowering a mammal's blood glucose level.
Career Highlights
Lora L Fitch is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to diabetes care and research. Her work at Eli Lilly has positioned her as a key player in the development of effective treatments for diabetes.
Collaborations
Throughout her career, Lora has collaborated with esteemed colleagues, including Klaus K Schmiegel and Samuel James Dominianni. These collaborations have further enhanced her research and innovation in the field of hypoglycemic agents.
Conclusion
Lora L Fitch's contributions to the development of hypoglycemic agents demonstrate her dedication to improving diabetes management. Her innovative patents and collaborations highlight her role as a significant inventor in the pharmaceutical industry.